Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,938,613 papers from all fields of science
Search
Sign In
Create Free Account
AZD6738
Known as:
ATR Kinase Inhibitor AZD6738
, AZD-6738
An orally available morpholino-pyrimidine-based inhibitor of ataxia telangiectasia and rad3 related (ATR) kinase, with potential antineoplastic…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
NCIt Antineoplastic Agent Terminology
Broader (2)
Pyrimidines
Sulfoxides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract CT135: A pre-surgical window of opportunity study to investigate the biomarker effects of DNA damage response (DDR) agents in patients (pts) with head and neck squamous cell carcinoma (HNSCC…
U. Duvvuri
,
E. Dean
,
+6 authors
A. Pierce
Clinical Trials
2018
Corpus ID: 81656719
Background: The annual incidence of head and neck cancers is >550,000 cases worldwide and approximately 90% are HNSCC. Treatment…
Expand
2018
2018
Synergistic effects of combining PARP inhibitor (AZD2281) and ATR inhibitor (AZD6738) in Ewing Sarcoma cell lines
S. C. Meyer
2018
Corpus ID: 106109548
2015
2015
Abstract LB-107: Targeting ATR using a novel ATR inhibitor AZD6738 in human gastric cancer cells
A. Min
,
S. Im
,
+10 authors
Y. Bang
2015
Corpus ID: 78773774
2015
2015
Abstract LB-165: Antiproliferative effects of AZD6738 and the inhibition of DDR activity
Hee-Jun Kim
,
A. Min
,
+10 authors
Y. Bang
2015
Corpus ID: 57967505
2014
2014
ATR Inhibition Exacerbates Replication Stress in TP53 or ATM Deficient CLL Cells and Enhances Sensitivity to Chemotherapy and Targeted Therapy
M. Kwok
,
N. Davies
,
+6 authors
T. Stankovic
2014
Corpus ID: 208431643
DNA damage response (DDR) defects, particularly TP53 or biallelic ATM aberrations, are associated with chemoresistance in chronic…
Expand